Cronos Group (CRON) Projected to Announce Earnings on Thursday

Cronos Group (NASDAQ:CRON) is anticipated to issue its Q3 2026 results before the market opens on Thursday, November 5th. Analysts expect the company to post earnings of $0.03 per share and revenue of $51.15 million for the quarter. Individuals can find conference call details on the company’s upcoming Q3 2026 earnings results page for the latest details on the call scheduled for Thursday, November 5, 2026 at 8:30 AM ET.

Cronos Group (NASDAQ:CRON) last posted its earnings results on Thursday, August 6th. The company reported $0.09 EPS for the quarter, topping the consensus estimate of $0.01 by $0.08. The firm had revenue of $53.01 million for the quarter, compared to analysts’ expectations of $44.20 million. Cronos Group had a net margin of 39.08% and a return on equity of 4.85%. On average, analysts expect Cronos Group to post $0.12 EPS for the current fiscal year and $0.25 EPS for the next fiscal year.

Cronos Group Trading Up 0.9%

Shares of CRON opened at $3.33 on Tuesday. The stock has a 50 day moving average of $3.30 and a 200 day moving average of $2.86. The company has a market capitalization of $1.23 billion, a price-to-earnings ratio of 30.45 and a beta of 0.90. Cronos Group has a 12 month low of $2.28 and a 12 month high of $3.61.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on the company. Zacks Research raised Cronos Group from a “hold” rating to a “strong-buy” rating in a research report on Thursday, October 22nd. TD Securities reissued a “buy” rating on shares of Cronos Group in a report on Monday, September 28th. Wall Street Zen lowered shares of Cronos Group from a “buy” rating to a “hold” rating in a research report on Saturday, August 15th. Finally, Weiss Ratings upgraded shares of Cronos Group from a “buy (b-)” rating to a “buy (b)” rating in a research report on Thursday, October 8th. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and one has given a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of “Buy” and an average target price of $2.30.

About Cronos Group

Cronos Group Inc is a Canadian cannabinoid company focused on developing, producing and commercializing cannabis and cannabis-derived consumer products. The company serves adult-use and medical cannabis markets through a portfolio of brands and sells products such as dried flower, pre-rolls, vaporizers, edibles, oils and other cannabis formats, subject to applicable regulations.

Its brand portfolio has included Spinach, which is positioned primarily in the adult-use cannabis market, as well as Lord Jones and PEACE NATURALS.